Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Baldassarre D, Iacoviello L, Baetta R, Roncaglioni MC, Condorelli G, Remuzzi G, Gensini G, Frati L, Ricciardi W, Conaldi PG, Uccelli A, Blandini F, Bosari S, Scambia G, Fini M, Di Malta A, Amato M, Veglia F, Bonomi A, Klersy C, Colazzo F, Pengo M, Gorini F, Auteri L, Ferrante G, Baviera M, Ambrosio G, Catapano A, Gialluisi A, Malavazos AE, Castelvecchio S, Corsi-Romanelli MM, Cardani R, La Rovere MT, Agnese V, Pane B, Prati D, Spinardi L, Liuzzo G, Arbustini E, Volterrani M, Visconti M, Werba JP, Genovese S, Bilo G, Invitti C, Di Blasio A, Lombardi C, Faini A, Rosa D, Ojeda-Fernández L, Foresta A, De Curtis A, Di Castelnuovo A, Scalvini S, Pierobon A, Gorini A, Valenti L, Luzi L, Racca A, Bandi M, Tremoli E, Menicanti L, Parati G, Pompilio G; CV-PREVITAL Study Group. Baldassarre D, et al. Among authors: malavazos ae. BMJ Open. 2023 Jul 14;13(7):e072040. doi: 10.1136/bmjopen-2023-072040. BMJ Open. 2023. PMID: 37451717 Free PMC article. Clinical Trial.
Epicardial fat thickness in type 2 diabetes outpatient care.
Iacobellis G, Goldberger JJ, Malavazos AE, Munoz Sterling CG, Canturk A. Iacobellis G, et al. Among authors: malavazos ae. Nutr Metab Cardiovasc Dis. 2024 Mar;34(3):618-623. doi: 10.1016/j.numecd.2023.10.016. Epub 2023 Oct 18. Nutr Metab Cardiovasc Dis. 2024. PMID: 38151435
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy.
Buscemi S, Davoli C, Trecarichi EM, Morrone HL, Tassone B, Buscemi C, Randazzo C, Barile AM, Colombrita P, Soresi M, Giannitrapani L, Cascio A, Scichilone N, Cottone C, Sbraccia P, Guglielmi V, Leonetti F, Malavazos AE, Basilico S, Carruba M, Santini F, Antonelli A, Viola N, Romano M, Cesana BM, Torti C. Buscemi S, et al. Among authors: malavazos ae. J Infect Public Health. 2023 Apr;16(4):520-525. doi: 10.1016/j.jiph.2023.02.002. Epub 2023 Feb 7. J Infect Public Health. 2023. PMID: 36801631 Free PMC article.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and Previous SARS-CoV-2 Infection.
Malavazos AE, Dubini C, Milani V, Boveri S, Meregalli C, Bertolini C, Buscemi C, Cardani R, Renna LV, Trevisan MB, Scravaglieri V, Cuppone MT, Menicanti L, Costa E, Ambrogi F, Ruocco C, Carruba M, Iacobellis G, Nisoli E, Corsi Romanelli MM. Malavazos AE, et al. Vaccines (Basel). 2023 Nov 30;11(12):1796. doi: 10.3390/vaccines11121796. Vaccines (Basel). 2023. PMID: 38140200 Free PMC article.
Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes.
Malavazos AE, Meregalli C, Sorrentino F, Vignati A, Dubini C, Scravaglieri V, Basilico S, Boniardi F, Spagnolo P, Malagoli P, Romanelli P, Secchi F, Iacobellis G. Malavazos AE, et al. Endocrinol Diabetes Metab Case Rep. 2023 Aug 8;2023(3):23-0017. doi: 10.1530/EDM-23-0017. Endocrinol Diabetes Metab Case Rep. 2023. PMID: 37551923 Free PMC article.
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers.
Renna LV, Bertani F, Podio A, Boveri S, Carrara M, Pinton A, Milani V, Spuria G, Nizza AF, Basilico S, Dubini C, Cerri A, Menicanti L, Corsi-Romanelli MM, Malavazos AE, Cardani R. Renna LV, et al. Among authors: malavazos ae. Vaccines (Basel). 2023 Feb 17;11(2):463. doi: 10.3390/vaccines11020463. Vaccines (Basel). 2023. PMID: 36851340 Free PMC article.
Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C, Menicanti L, Vianello E, Meregalli C, Ruocco C, Ragni M, Secchi F, Spagnolo P, Castelvecchio S, Morricone L, Buscemi S, Giordano A, Goldberger JJ, Carruba M, Cinti S, Corsi Romanelli MM, Nisoli E. Malavazos AE, et al. Eur J Prev Cardiol. 2023 Jun 1;30(8):680-693. doi: 10.1093/eurjpc/zwad050. Eur J Prev Cardiol. 2023. PMID: 36799940
79 results